[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585050":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":27,"locations":32,"responsibleParty":49,"collaborators":11,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":11,"enrollmentInfo":62,"targetDuration":11,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":11,"overallStatus":71,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"HFT","EXPERIMENTAL",null,[13],"Device: High-Flow Tracheal Therapy",{"label":15,"type":16,"description":11,"interventionNames":11},"Control","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"DEVICE","High-Flow Tracheal Therapy","Device: Airvo 2 (Fisher \\& Paykel Healthcare) Settings: Flow rate start at 40L\u002Fmin and will be adapted according to tolerance; temperature aimed at 37°C or 34°C according to tolerance, FiO₂ set (if needed) according to SpO2 target values.",[9],[24],{"name":25,"affiliation":5,"role":26},"William Poncin, PhD","PRINCIPAL_INVESTIGATOR",[28],{"name":25,"role":29,"phone":30,"phoneExt":11,"email":31},"CONTACT","+3227641111","william.poncin@uclouvain.be",[33],{"facility":34,"status":11,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Cliniques universitaires Saint-Luc","Brussels","Brussels Capital","1200","Belgium","BE",{"type":41,"coordinates":42},"Point",[43,44],4.34878,50.85045,{"lat":44,"lon":43},[47],{"name":48,"role":29,"phone":30,"phoneExt":11,"email":31},"William Poncin",{"type":26,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"William Poncin, PT, PhD","Principal Investigator","100585050","high-flow-tracheal-therapy-on-tracheobronchial-secretions-in-tracheostomized-patients-100585050",false,"NCT06897319","High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients","Impact of High-Flow Tracheal Therapy on the Rheological Properties of Tracheobronchial Secretions in Tracheostomized Patients: A Randomized Crossover Study.","TRACH2O","Inclusion Criteria:\n\n* Adult patients (≥18 years old)\n* Tracheostomized patients\n* Patients requiring routine tracheal suctioning and already using HFT overnight\n\nExclusion Criteria:\n\n* Insufficient secretions for analysis\n* Cognitive impairment or confusion","ALL","18 Years",{"count":63,"type":64},15,"ESTIMATED","INTERVENTIONAL",[67],"NA","This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.",[70],"Tracheostomized Patients","NOT_YET_RECRUITING","2026-04-22",{"date":74,"type":75},"2026-04-27","ACTUAL",{"date":77,"type":64},"2026-06-20",{"date":79,"type":64},"2027-08-01",{"name":5,"class":6},1]